FindMyRecallSubscribe
Class I: serious health riskTerminated

B. Braun Medical Hyperlyte CR Recall

Hyperlyte CR (Multi-Electrolyte Concentrate), 20 mL/dose, 250 mL Container, Catalog No

B. Braun Medical Inc · Irvine, CA

Risk level
Class I
Reported by FDA
May 7, 2014
Recall ID
D-1275-2014
Check your lot numberHow we source this data

Summary

B. Braun Medical recalled Hyperlyte CR starting Nov 21, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-1275-2014 on May 7, 2014. Reason: Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Product description

Hyperlyte CR (Multi-Electrolyte Concentrate), 20 mL/dose, 250 mL Container, Catalog No. S9432, Rx Only, Sterile, B Braun Medical Inc., Irvine CA 92614-5895, In Canada Dist by: B Braun Medical Inc., Scarborough, Ontario M1H 2W4, NDC 0264-1943-20, Canada DIN 01924311

Lot numbers, UPCs & expiration codes

Lot# J3B007, Exp 08/14

Where it was sold

Nationwide, Puerto Rico and Spain

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1275-2014
Classification
Class I
Status
Terminated
Recall initiated
Nov 21, 2013
FDA report date
May 7, 2014
Quantity
5,592 units
Recall type
Voluntary: Firm initiated
Recalling firm
B. Braun Medical Inc

Original FDA data

Every field from FDA enforcement report D-1275-2014, exactly as published.

Show all FDA fields
City
Irvine
State
CA
Status
Terminated
Country
United States
Event ID
66913
Address
2525 McGaw Ave
Code information
Lot# J3B007, Exp 08/14
Postal code
92614-5841
Report date
May 7, 2014
Product type
Drugs
Recall number
D-1275-2014
Classification
Class I
Recalling firm
B. Braun Medical Inc
Product quantity
5,592 units
Termination date
Dec 4, 2014
Reason for recall
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hyperlyte CR (Multi-Electrolyte Concentrate), 20 mL/dose, 250 mL Container, Catalog No. S9432, Rx Only, Sterile, B Braun Medical Inc., Irvine CA 92614-5895, In Canada Dist by: B Braun Medical Inc., Scarborough, Ontario M1H 2W4, NDC 0264-1943-20, Canada DIN 01924311
Distribution pattern
Nationwide, Puerto Rico and Spain
Recall initiation date
Nov 21, 2013
Initial firm notification
Letter
Center classification date
Apr 25, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1275-2014, published May 7, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls